How much revenue did Chemours generate this year?
Chemours has achieved a revenue of 5.91 B USD this year.
Chemours Revenue 2024
Chemours Revenue
5.91 B USD
Ticker
CC
ISIN
US1638511089
WKN
A14RPH
In 2024, Chemours's sales reached 5.91 B USD, a -1.96% difference from the 6.03 B USD sales recorded in the previous year.
The Chemours Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 6.53 | 19,99 |
| 2025e | 6.19 | 21,09 |
| 2024e | 5.91 | 22,10 |
| 2023 | 6.03 | 21,67 |
| 2022 | 6.79 | 23,79 |
| 2021 | 6.35 | 21,77 |
| 2020 | 4.97 | 21,47 |
| 2019 | 5.53 | 19,24 |
| 2018 | 6.64 | 29,69 |
| 2017 | 6.18 | 28,22 |
| 2016 | 5.4 | 20,43 |
| 2015 | 5.72 | 16,70 |
| 2014 | 6.43 | 21,14 |
| 2013 | 6.86 | 21,34 |
| 2012 | 7.37 | 31,92 |
| 2011 | 7.97 | 32,58 |
Chemours Revenue, EBIT, Net Income US1638511089 · A14RPH
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Chemours, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chemours from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chemours’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Chemours. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Chemours’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Chemours’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chemours’s growth potential.
Chemours Revenue, EBIT and net profit per share
| Date | Chemours Revenue | Chemours EBIT | Chemours Net Income |
|---|---|---|---|
| 2026e | 6.53 B undefined | 824.68 M undefined | 489.57 M undefined |
| 2025e | 6.19 B undefined | 677.43 M undefined | 354.12 M undefined |
| 2024e | 5.91 B undefined | 464.34 M undefined | 197.68 M undefined |
| 2023 | 6.03 B undefined | -92 M undefined | -238 M undefined |
| 2022 | 6.79 B undefined | 788 M undefined | 578 M undefined |
| 2021 | 6.35 B undefined | 682 M undefined | 608 M undefined |
| 2020 | 4.97 B undefined | 447 M undefined | 219 M undefined |
| 2019 | 5.53 B undefined | 435 M undefined | -52 M undefined |
| 2018 | 6.64 B undefined | 1.3 B undefined | 995 M undefined |
| 2017 | 6.18 B undefined | 1.04 B undefined | 746 M undefined |
| 2016 | 5.4 B undefined | 411 M undefined | 7 M undefined |
| 2015 | 5.72 B undefined | 226 M undefined | -90 M undefined |
| 2014 | 6.43 B undefined | 532 M undefined | 400 M undefined |
| 2013 | 6.86 B undefined | 532 M undefined | 423 M undefined |
| 2012 | 7.37 B undefined | 1.46 B undefined | 1.06 B undefined |
| 2011 | 7.97 B undefined | 1.73 B undefined | 1.43 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 7.97 B USD | 1.73 B USD | 1.43 B USD |
| 2012 | 7.37 B USD | 1.46 B USD | 1.06 B USD |
| 2013 | 6.86 B USD | 532 M USD | 423 M USD |
| 2014 | 6.43 B USD | 532 M USD | 400 M USD |
| 2015 | 5.72 B USD | 226 M USD | -90 M USD |
| 2016 | 5.4 B USD | 411 M USD | 7 M USD |
| 2017 | 6.18 B USD | 1.04 B USD | 746 M USD |
| 2018 | 6.64 B USD | 1.3 B USD | 995 M USD |
| 2019 | 5.53 B USD | 435 M USD | -52 M USD |
| 2020 | 4.97 B USD | 447 M USD | 219 M USD |
| 2021 | 6.35 B USD | 682 M USD | 608 M USD |
| 2022 | 6.79 B USD | 788 M USD | 578 M USD |
| 2023 | 6.03 B USD | -92 M USD | -238 M USD |
| 2024e | 5.91 B USD | 464.34 M USD | 197.68 M USD |
| 2025e | 6.19 B USD | 677.43 M USD | 354.12 M USD |
| 2026e | 6.53 B USD | 824.68 M USD | 489.57 M USD |
Chemours stock margins US1638511089 · A14RPH
The Chemours margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemours. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemours.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Chemours's sales revenue. A higher gross margin percentage indicates that the Chemours retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Chemours's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Chemours's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chemours's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chemours. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chemours's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Chemours Margin History
| Chemours Gross margin | Chemours Profit margin | Chemours EBIT margin | Chemours Profit margin |
|---|---|---|---|
| 2026e | 21.67 % | 12.63 % | 7.49 % |
| 2025e | 21.67 % | 10.94 % | 5.72 % |
| 2024e | 21.67 % | 7.86 % | 3.35 % |
| 2023 | 21.67 % | -1.53 % | -3.95 % |
| 2022 | 23.79 % | 11.6 % | 8.51 % |
| 2021 | 21.77 % | 10.75 % | 9.58 % |
| 2020 | 21.47 % | 9 % | 4.41 % |
| 2019 | 19.24 % | 7.87 % | -0.94 % |
| 2018 | 29.69 % | 19.51 % | 14.99 % |
| 2017 | 28.22 % | 16.79 % | 12.07 % |
| 2016 | 20.43 % | 7.61 % | 0.13 % |
| 2015 | 16.7 % | 3.95 % | -1.57 % |
| 2014 | 21.14 % | 8.27 % | 6.22 % |
| 2013 | 21.34 % | 7.76 % | 6.17 % |
| 2012 | 31.92 % | 19.81 % | 14.35 % |
| 2011 | 32.58 % | 21.71 % | 17.95 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 32.58 % | 21.71 % | 17.95 % |
| 2012 | 31.92 % | 19.81 % | 14.35 % |
| 2013 | 21.34 % | 7.76 % | 6.17 % |
| 2014 | 21.14 % | 8.27 % | 6.22 % |
| 2015 | 16.7 % | 3.95 % | -1.57 % |
| 2016 | 20.43 % | 7.61 % | 0.13 % |
| 2017 | 28.22 % | 16.79 % | 12.07 % |
| 2018 | 29.69 % | 19.51 % | 14.99 % |
| 2019 | 19.24 % | 7.87 % | -0.94 % |
| 2020 | 21.47 % | 9 % | 4.41 % |
| 2021 | 21.77 % | 10.75 % | 9.58 % |
| 2022 | 23.79 % | 11.6 % | 8.51 % |
| 2023 | 21.67 % | -1.53 % | -3.95 % |
| 2024e | 21.67 % | 7.86 % | 3.35 % |
| 2025e | 21.67 % | 10.94 % | 5.72 % |
| 2026e | 21.67 % | 12.63 % | 7.49 % |
Chemours Aktienanalyse
What does Chemours do?
Chemours Co is a US-based chemical company that emerged from the DuPont Performance Chemicals division in 2015. With its headquarters in Wilmington, Delaware, the company employs over 7,000 employees worldwide and has an annual revenue of approximately $6 billion. The company's history dates back to 1802 when Eleuthère Irénée DuPont de Nemours established a powder mill in Wilmington. Over time, DuPont specialized in the production of chemicals for various applications including textiles, electronics, construction, transportation, and food. In 2015, the DuPont Performance Chemicals division was spun off as an independent company under the name Chemours Co. Chemours' business model is based on the development and production of chemicals for various applications including titanium dioxide pigments, fluoroproducts, Nafion membranes, Freon refrigerants, and optical materials. These products are utilized by various industries such as automotive, construction, chemicals, and electronics. The company is divided into three segments: Titanium Technologies, Fluor Technologies, and Chemical Solutions. Chemours' titanium dioxide pigments are produced in the Titanium Technologies segment and are a crucial component in paints, plastics, paper, and other materials. Fluor products, such as refrigerants and fluoropolymer coatings, are manufactured by the Fluor Technologies segment and find application in aerospace, automotive, and semiconductor production. The Chemical Solutions segment produces various chemicals for use in agriculture, oil and gas industry, fuel cell production, and other areas. One well-known product of Chemours is the refrigerant R-134a, marketed under the brand name Freon. This refrigerant was developed in the 1990s as a replacement for the ozone-depleting refrigerant R-12 (Freon 12) and is now widely used in vehicle air conditioning systems and other cooling systems. Another product of Chemours is Nafion membranes, used in fuel cells. These membranes enable the electrochemical reaction that converts hydrogen into electricity and water. Fuel cells are considered an environmentally-friendly energy source for vehicles and buildings. Chemours aims to produce chemicals that are safe, environmentally friendly, and sustainable. The company has developed its own sustainability strategy, which aims to reduce resource consumption, decrease dependence on non-renewable resources, and minimize environmental impact. Chemours has also implemented a comprehensive product safety and quality policy to ensure that all products meet the highest safety and quality standards. Overall, Chemours is a leading provider of chemicals used in a variety of industries. The company is committed to sustainability and product safety and is dedicated to continuously improving its processes and products. Chemours ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Chemours's Sales Figures
The sales figures of Chemours originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Chemours’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Chemours's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Chemours’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Chemours stock
How much was the turnover of the company Chemours compared to the previous year?
The revenue of Chemours has increased by -1.96% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Chemours?
The revenue of Chemours is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Chemours measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Chemours so important for investors?
The revenue of Chemours is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Chemours pay?
Over the past 12 months, Chemours paid a dividend of 1 USD . This corresponds to a dividend yield of about 5.29 %. For the coming 12 months, Chemours is expected to pay a dividend of 1.34 USD.
What is the dividend yield of Chemours?
The current dividend yield of Chemours is 5.29 %.
When does Chemours pay dividends?
Chemours pays a quarterly dividend. This is distributed in the months of March, June, September, December.
How secure is the dividend of Chemours?
Chemours paid dividends every year for the past 12 years.
What is the dividend of Chemours?
For the upcoming 12 months, dividends amounting to 1.34 USD are expected. This corresponds to a dividend yield of 7.1 %.
In which sector is Chemours located?
Chemours is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Chemours kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chemours from 12/16/2024 amounting to 0.25 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.
When did Chemours pay the last dividend?
The last dividend was paid out on 12/16/2024.
What was the dividend of Chemours in the year 2023?
In the year 2023, Chemours distributed 1 USD as dividends.
In which currency does Chemours pay out the dividend?
The dividends of Chemours are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Chemours stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Chemours
Our stock analysis for Chemours Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemours Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
